SCISCIOLA, Lucia
 Distribuzione geografica
Continente #
EU - Europa 913
NA - Nord America 473
AS - Asia 53
OC - Oceania 5
SA - Sud America 2
Totale 1.446
Nazione #
US - Stati Uniti d'America 471
IT - Italia 395
IE - Irlanda 300
DE - Germania 51
GB - Regno Unito 45
DK - Danimarca 37
CN - Cina 27
FR - Francia 21
UA - Ucraina 19
SE - Svezia 11
NL - Olanda 10
GR - Grecia 9
FI - Finlandia 6
AU - Australia 5
JP - Giappone 5
IL - Israele 4
TR - Turchia 4
HK - Hong Kong 3
IN - India 3
BE - Belgio 2
CA - Canada 2
ES - Italia 2
KR - Corea 2
PK - Pakistan 2
PL - Polonia 2
VE - Venezuela 2
VN - Vietnam 2
AT - Austria 1
LU - Lussemburgo 1
PT - Portogallo 1
TW - Taiwan 1
Totale 1.446
Città #
Dublin 300
Chandler 129
Naples 84
Caserta 49
Juelsminde 37
Jacksonville 35
Princeton 26
Roxbury 26
Bremen 25
New York 24
Cambridge 19
Beijing 17
Napoli 17
Wilmington 12
Rome 11
Medford 9
Tyresö 9
Bari 8
Milan 8
Boardman 6
Mountain View 6
Amsterdam 5
Munich 5
Seregno 5
Sydney 5
Ann Arbor 4
Barak 4
Boydton 4
Des Moines 4
Houston 4
Niigata 4
Oristano 4
Salerno 4
Ashburn 3
Carinaro 3
Castellammare di Stabia 3
Giugliano In Campania 3
Lappeenranta 3
Maddaloni 3
Nanjing 3
Nola 3
Quartu Sant'elena 3
Redwood City 3
Selargius 3
Aversa 2
Brussels 2
Buffalo 2
Caracas 2
Cava de' Tirreni 2
Dong Ket 2
Elora 2
Florence 2
Gualtieri 2
Karachi 2
London 2
Massa 2
Pian di Scò 2
Rotterdam 2
San Mateo 2
San Nicola la Strada 2
Sant'angelo D'alife 2
Santa Maria Capua Vetere 2
Seattle 2
Shanghai 2
Vicenza 2
Alghero 1
Avellino 1
Barcelona 1
Barreiro 1
Berlin 1
Bologna 1
Caivano 1
Canterbury 1
Casagiove 1
Casalnuovo di Napoli 1
Casaluce 1
Casavatore 1
Cava Dei Tirreni 1
Cogne 1
Dallas 1
Düsseldorf 1
Ferrara 1
Fisciano 1
Foggia 1
Hebei 1
Helsinki 1
Hong Kong 1
Hyderabad 1
Jinan 1
Kharkiv 1
L'aquila 1
Lamezia Terme 1
Limatola 1
Luxembourg 1
Madrid 1
Matera 1
Melle 1
Monte Compatri 1
Montesarchio 1
Monza 1
Totale 1.019
Nome #
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 101
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients 81
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: Effects of metformin 69
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 69
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 65
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 61
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 59
Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells 56
Combined HAT/EZH2 modulation leads to cancer-selective cell death 52
Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study 52
ATTIVATORI DI SIRTUINE E LORO USI 45
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 44
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 40
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia 40
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts 40
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells 39
New insight in molecular mechanisms regulating SIRT6 expression in diabetes: Hyperglycaemia effects on SIRT6 DNA methylation 38
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 37
Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complications 36
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 33
Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors 31
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction 30
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? 30
miR-21 in Human Cardiomyopathies 29
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 28
Atherosclerotic plaque fissuration and clinical outcomes in pre-diabetics vs. normoglycemics patients affected by asymptomatic significant carotid artery stenosis at 2 years of follow-up: Role of micrornas modulation: The atimir study 28
The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: Evidence in human cardiomyocyte cell line 26
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 25
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 24
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 24
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors 24
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes 22
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 22
Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk 21
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 19
Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line 18
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 16
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 14
Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study 14
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 14
Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes 9
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 8
Tirzepatide prevents neurodegeneration through multiple molecular pathways 6
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque 5
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists 4
On the wake of metformin: Do anti-diabetic SGLT2 inhibitors exert anti-aging effects? 2
Totale 1.550
Categoria #
all - tutte 6.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 2 1
2019/2020100 12 5 5 16 8 2 13 12 11 6 5 5
2020/2021162 4 16 20 5 15 1 17 13 27 14 27 3
2021/2022259 12 5 16 12 46 8 20 10 16 34 17 63
2022/2023597 40 24 25 23 66 35 31 32 284 11 13 13
2023/2024355 24 30 31 22 77 76 20 17 19 33 6 0
Totale 1.550